Bristol Myers Squibb (BMS) has announced that its dual immunotherapy combination has been recommended by the National ...

Phase Ib Study of BI 836880 (VEGF/Ang2 nanobody) in Combination With Ezabenlimab (anti–PD-1 antibody) in Patients With Advanced or Metastatic Solid Tumors There have been significant advances in ...

Bret Hulick was in his second year of medical school at LECOM in Erie, analyzing the case of a 24-year-old colon cancer ...

DelveInsight’s, “Metastatic Colorectal Cancer Pipeline Insight 2025” report provides comprehensive insights about 150+ ...

Portuguese researchers have discovered that a type of white blood cell that can identify and kill tumour cells could be the key to a new immunotherapy against colorectal cancer, the most common type ...

Researchers retrospectively analysed data from 368 patients with MSI-H colon cancer across two academic centres. Patients ...

The precise use of immunotherapy agents in locally advanced head and neck squamous cell carcinoma has not been clearly ...

Portuguese researchers working to advance colorectal cancer treatment have discovered a new type of white blood cell that could open the door to more ...

A new implant safely triggers potent immune responses against hard-to-treat cancers showing "promise" for pancreatic and ...

Real-world data show that immunotherapy leads to better overall ... association between higher dairy intake and lower colorectal cancer risk.

Press Release Distributed by ABNewswire.com To view the original version on ABNewswire visit: Microsatellite Stable ...

Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for ...